NIAID Site Search

Sample application from Emily Troemel, Ph.D., for NIH standard independent research project grant (R01).

Last Reviewed: October 11, 2024

Sample application from David Al-Adra MD, Ph.D., for NIH standard independent research project grant (K08).

Last Reviewed: September 13, 2024

Last Reviewed: August 6, 2024

Michail Lionakis, M.D., Sc.D., is Chief of the Laboratory of Clinical Immunology and Microbiology and the Chief of the Fungal Pathogenesis Section. The section's research focuses on 1) cellular and molecular factors that regulate the immune response against mucosal and invasive candidiasis and invasive aspergillosis in clinically relevant animal models and 2) better understanding the genetic and immune defects that underlie enhanced susceptibility to mucocutaneous and invasive fungal infections in humans.

Last Reviewed: February 18, 2025

Last Reviewed: August 6, 2024

Sample application from Benjamin Delbert Brooks, Ph.D., for Small Business Technology Transfer (STTR) grant (R43).

Last Reviewed: November 25, 2022

Office of Research on Women’s Health and NIH Support for Research on Women’s Health Report of the Advisory Committee on Research on Women’s Health: Fiscal Years 2019–2020 508-compliant PDF

Last Reviewed: March 8, 2022

Niki M. Moutsopoulos, D.D.S., Ph.D., is Chief of the Laboratory of Host Immunity and Microbiome and the Chief of the Human Barrier Immunity Section.

Last Reviewed: February 20, 2025

Sample application from Mohammad Ayoub Mir

Last Reviewed: August 4, 2017

Last Reviewed: November 14, 2024

Opportunistic fungal infections represent major causes of morbidity and mortality despite the administration of antifungal therapy. A better mechanistic understanding of host-fungal interactions will inform the development of improved immune-based strategies for the prevention, risk stratification, prognostication, vaccination, and treatment of vulnerable patient populations. In the Fungal

Last Reviewed: February 18, 2025

This document provides a progress report about the Biodefense Research Agenda for CDC Category A Agents in 2006.

Last Reviewed: August 6, 2019

Jordan Report: Accelerated Development of Vaccines (2002) from NIAID includes updates on vaccine research for specific infectious diseases.

Last Reviewed: December 31, 2002